| Differential equations driven by rough paths TJ Lyons, Michael. Caruana, Thierry. Lévy Springer, 2007 | 695 | 2007 |
| Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries M Brisson, JJ Kim, K Canfell, M Drolet, G Gingras, EA Burger, D Martin, ... The Lancet 395 (10224), 575-590, 2020 | 616 | 2020 |
| Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries K Canfell, JJ Kim, M Brisson, A Keane, KT Simms, M Caruana, EA Burger, ... The Lancet 395 (10224), 591-603, 2020 | 444 | 2020 |
| Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020–99: a modelling study KT Simms, J Steinberg, M Caruana, MA Smith, JB Lew, I Soerjomataram, ... The Lancet Oncology 20 (3), 394-407, 2019 | 418 | 2019 |
| Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National … JB Lew, KT Simms, MA Smith, M Hall, YJ Kang, XM Xu, M Caruana, ... The Lancet Public Health 2 (2), e96-e107, 2017 | 178 | 2017 |
| Long-term evaluation of benefits, harms, and cost-effectiveness of the National Bowel Cancer Screening Program in Australia: a modelling study JB Lew, DJB St John, XM Xu, MJE Greuter, M Caruana, DR Cenin, E He, ... The Lancet Public Health 2 (7), e331-e340, 2017 | 150 | 2017 |
| Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of … K Canfell, M Caruana, V Gebski, J Darlington-Brown, S Heley, ... PLoS medicine 14 (9), e1002388, 2017 | 114 | 2017 |
| A (rough) pathwise approach to a class of non-linear stochastic partial differential equations M Caruana, PK Friz, H Oberhauser Annales de l'Institut Henri Poincaré C, Analyse non linéaire 28 (1), 27-46, 2011 | 102 | 2011 |
| Identifying high risk individuals for targeted lung cancer screening: Independent validation of the PLCOm2012 risk prediction tool M Weber, S Yap, D Goldsbury, D Manners, M Tammemagi, H Marshall, ... International Journal of Cancer 141 (2), 242-253, 2017 | 87 | 2017 |
| Partial differential equations driven by rough paths M Caruana, P Friz Journal of Differential Equations 247 (1), 140-173, 2009 | 73 | 2009 |
| Cancer incidence and mortality in Australia from 2020 to 2044 and an exploratory analysis of the potential effect of treatment delays during the COVID-19 pandemic: a … Q Luo, DL O’Connell, XQ Yu, C Kahn, M Caruana, F Pesola, P Sasieni, ... The Lancet Public Health 7 (6), e537-e548, 2022 | 53 | 2022 |
| Cost-effectiveness of the next generation nonavalent human papillomavirus vaccine in the context of primary human papillomavirus screening in Australia: a comparative modelling … KT Simms, JF Laprise, MA Smith, JB Lew, M Caruana, M Brisson, ... The Lancet Public Health 1 (2), e66-e75, 2016 | 52 | 2016 |
| Estimating the cost-effectiveness of lung cancer screening with low-dose computed tomography for high-risk smokers in Australia S Wade, M Weber, M Caruana, YJ Kang, H Marshall, R Manser, S Vinod, ... Journal of Thoracic Oncology 13 (8), 1094-1105, 2018 | 50 | 2018 |
| Evaluation of the benefits, harms and cost‐effectiveness of potential alternatives to iFOBT testing for colorectal cancer screening in Australia JB Lew, DJB St. John, FA Macrae, JD Emery, HC Ee, MA Jenkins, E He, ... International journal of cancer 143 (2), 269-282, 2018 | 44 | 2018 |
| Tobacco smoking changes during the first pre-vaccination phases of the COVID-19 pandemic: A systematic review and meta-analysis P Sarich, CJ Cabasag, E Liebermann, P Vaneckova, C Carle, S Hughes, ... EClinicalMedicine 47, 2022 | 42 | 2022 |
| Association Between Melanoma Detected During Routine Skin Checks and Mortality CG Watts, K McLoughlin, C Goumas, CH Van Kemenade, JF Aitken, ... JAMA dermatology 157 (12), 1425-1436, 2021 | 41 | 2021 |
| Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates JB Lew, E Feletto, S Wade, M Caruana, YJ Kang, C Nickson, K Simms, ... Public health research & practice 29 (2), 2019 | 41 | 2019 |
| National Cervical Screening Program Renewal: Effectiveness modelling and economic evaluation in the Australian setting JB Lew, KT Simms, MA Smith, YK Kang, X Xu, M Caruana, R Walker, ... | 37 | 2013 |
| Benefits, harms, and cost-effectiveness of potential age extensions to the national bowel cancer screening program in Australia JB Lew, DJB St John, FA Macrae, JD Emery, HC Ee, MA Jenkins, E He, ... Cancer Epidemiology and Prevention Biomarkers 27 (12), 1450-1461, 2018 | 35 | 2018 |
| Lung cancer mortality in Australia: Projected outcomes to 2040 Q Luo, XQ Yu, S Wade, M Caruana, F Pesola, K Canfell, DL O’Connell Lung Cancer 125, 68-76, 2018 | 35 | 2018 |
Peter K. FrizProfessor of Mathematics, TU and WIAS BerlinVerified email at math.tu-berlin.de
